In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014

BACKGROUND: Malaria causes significant morbidity in Malawi, with an estimated 5 million cases in 2014. Artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) are the first- and second-line treatments for uncomplicated malaria, respectively, but emerging resistance threatens their efficacy. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Paczkowski, Magdalena, Mwandama, Dyson, Marthey, Daniel, Luka, Madalitso, Makuta, Georgina, Sande, John, Ali, Doreen, Troell, Peter, Mathanga, Don P., Gutman, Julie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845327/
https://www.ncbi.nlm.nih.gov/pubmed/27113085
http://dx.doi.org/10.1186/s12936-016-1281-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845327/
https://www.ncbi.nlm.nih.gov/pubmed/27113085
http://dx.doi.org/10.1186/s12936-016-1281-y

Ejemplares similares